| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Alsonex Pharmaceuticals is developing a peptide inhibitor of complement factor C5aR1 for the treatment of neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis. |
| Category: | Health & biotech |
| URL: | http://alsonex.com.au |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2016 |
| Address: | Brisbane, Queensland 4000, AU |
| State: | Queensland |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/alsonex/ |
| Founders: |
No items found
|
| Awards won: | |
